RCS
Retirement Capital Strategies’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-79,806
| Closed | -$3.5M | – | 71 |
|
|
2021
Q4 | $3.5M | Sell |
79,806
-5,581
| -7% | -$244K | 1.28% | 18 |
|
|
2021
Q3 | $4.33M | Sell |
85,387
-87,147
| -51% | -$4.42M | 1.66% | 17 |
|
|
2021
Q2 | $8.98M | Buy |
172,534
+84,485
| +96% | +$4.4M | 3.42% | 8 |
|
|
2021
Q1 | $4.03M | Sell |
88,049
-4,125
| -4% | -$189K | 1.59% | 20 |
|
|
2020
Q4 | $4.23M | Sell |
92,174
-1,470
| -2% | -$67.5K | 1.72% | 19 |
|
|
2020
Q3 | $3.55M | Sell |
93,644
-155,788
| -62% | -$5.91M | 1.64% | 22 |
|
|
2020
Q2 | $9.47M | Buy |
+249,432
| New | +$9.47M | 4.5% | 7 |
|